AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Pulmonx Corporation (LUNG)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

8.74

2.10 (31.63%)

At close: Feb 20, 2025, 3:59 PM

8.82

0.92%

After-hours: Feb 20, 2025, 06:32 PM EST

undefined% (undefined)

Bid	8.82
Market Cap	345.12M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-1.47
PE Ratio (ttm)	-5.95
Forward PE	n/a
Analyst	Buy

Ask	8.92
Volume	2,806,602
Avg. Volume (20D)	228,484
Open	7.60
Previous Close	6.64
Day's Range	7.60 - 9.37
52-Week Range	5.46 - 14.20
Beta	undefined

About LUNG

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Oct 1, 2020

Employees 279

Stock Exchange NASDAQ

Ticker Symbol LUNG

Website https://pulmonx.com

Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for LUNG stock is "Buy." The 12-month stock price forecast is $12, which is an increase of 37.30% from the latest price.

Buy 66.67%

Hold 33.33%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Pulmonx Corporation is scheduled to release its earnings on Apr 30, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 day ago New

Pulmonx shares are trading higher after the compan... Unlock content with Pro Subscription

2 days ago New

-5.01%

Pulmonx shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY25 sales guidance above estimates.

News

2 days ago · seekingalpha.com

Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript

Pulmonx Corporation (NASDAQ:LUNG ) Q4 2024 Results Conference Call February 19, 2025 4:30 PM ET Company Participants Elizabeth Sparicio - Investor Relations Steve Williamson - President and Chief Exec...

2 days ago · zacks.com

Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates

Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.36 per share a year ago.

3 months ago · zacks.com

Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect?

The consensus price target hints at an 117.7% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimat...